RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • … III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture …

… III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture …

Add to Collection
RCTs H Zhang, J Gu, A Chao, Q Cheng, D Teng… - Acta pharmacologica …, 2023 - nature.com

Chapter : Section13
Journal Year : 2023
Cited by : 1

The current study evaluated the efficacy and safety of a denosumab biosimilar, QL1206 (60 mg), compared to placebo in postmenopausal Chinese women with osteoporosis and high …..... Read More

Keywords : ['iii randomize doubleblind placebocontrolle trial', 'postmenopausal chinese woman', 'high fracture', 'denosumab biosimilar', 'osteoporosis']
PubMed Link : https://www.nature.com/articles/s41401-022-00954-y
Google Scholar Link : https://scholar.google.com/scholar?cites=1560209331701699559&as_sdt=2005&sciodt=0,5&hl=en&num=20